Pharma Bio Valuation
| PBSV Stock | USD 0.50 0.05 9.09% |
Pharma Bio is overvalued. Pharma Bio Serv holds a recent Real Value of $0.43 per share. The prevailing price of the company is $0.5. Our model determines the value of Pharma Bio Serv from analyzing the company fundamentals such as Shares Outstanding of 22.95 M, operating margin of 0.06 %, and Return On Equity of 0.0568 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors support buying undervalued entities and disposing overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Pharma Bio's price fluctuation is out of control at this time. Calculation of the real value of Pharma Bio Serv is based on 3 months time horizon. Increasing Pharma Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Pharma otc stock is determined by what a typical buyer is willing to pay for full or partial control of Pharma Bio Serv. Since Pharma Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pharma OTC Stock. However, Pharma Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.5 | Real 0.43 | Hype 0.5 | Naive 0.54 |
The intrinsic value of Pharma Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Pharma Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Pharma Bio Serv helps investors to forecast how Pharma otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pharma Bio more accurately as focusing exclusively on Pharma Bio's fundamentals will not take into account other important factors: Pharma Bio Total Value Analysis
Pharma Bio Serv is at this time projected to have valuation of 4.87 M with market capitalization of 20.88 M, debt of 520.77 K, and cash on hands of 14.24 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Pharma Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.87 M | 20.88 M | 520.77 K | 14.24 M |
Pharma Bio Investor Information
About 65.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.15. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pharma Bio Serv last dividend was issued on the 24th of February 2022. Based on the analysis of Pharma Bio's profitability, liquidity, and operating efficiency, Pharma Bio Serv is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Pharma Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Pharma Bio has an asset utilization ratio of 93.94 percent. This indicates that the OTC Stock is making $0.94 for each dollar of assets. An increasing asset utilization means that Pharma Bio Serv is more efficient with each dollar of assets it utilizes for everyday operations.Pharma Bio Ownership Allocation
Pharma Bio owns a total of 22.95 Million outstanding shares. Pharma Bio holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.53 pct. of Pharma Bio Serv outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Pharma Bio Profitability Analysis
The company reported the previous year's revenue of 19.4 M. Net Income was 1.01 M with profit before overhead, payroll, taxes, and interest of 4.88 M.About Pharma Bio Valuation
Our relative valuation model uses a comparative analysis of Pharma Bio. We calculate exposure to Pharma Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pharma Bio's related companies.Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico. Pharma Bio operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 190 people.
8 Steps to conduct Pharma Bio's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Pharma Bio's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Pharma Bio's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Pharma Bio's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Pharma Bio's revenue streams: Identify Pharma Bio's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Pharma Bio's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Pharma Bio's growth potential: Evaluate Pharma Bio's management, business model, and growth potential.
- Determine Pharma Bio's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Pharma Bio's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Pharma Bio Growth Indicators
Investing in growth stocks can be very risky. If the company such as Pharma Bio does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 22.9 M | |
| Quarterly Earnings Growth Y O Y | -0.872 | |
| Retained Earnings | 15.3 M | |
| Forward Annual Dividend Rate | 0.07 | |
| Shares Float | 12.3 M |
Additional Tools for Pharma OTC Stock Analysis
When running Pharma Bio's price analysis, check to measure Pharma Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Bio is operating at the current time. Most of Pharma Bio's value examination focuses on studying past and present price action to predict the probability of Pharma Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Bio's price. Additionally, you may evaluate how the addition of Pharma Bio to your portfolios can decrease your overall portfolio volatility.